NYSEArca - Delayed Quote USD

Counterpoint Quantitative Equity ETF (CPAI)

29.23 -0.09 (-0.30%)
At close: April 25 at 2:59 PM EDT
Loading Chart for CPAI
DELL
  • Previous Close 29.32
  • Open 28.89
  • Bid 29.21 x 1800
  • Ask --
  • Day's Range 28.89 - 29.24
  • 52 Week Range 25.14 - 29.94
  • Volume 4,961
  • Avg. Volume 5,193
  • Net Assets 19.96M
  • NAV 29.21
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return 8.85%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.75%

Under normal market circumstances, the fund invests at least 80% of its assets in common stocks and American Depositary Receipts. The fund holds at least 50 U.S. listed stocks or American Depository Receipts. The stocks selected are of companies of any market capitalization and are among the highest-ranking stocks as determined by quantitative models. The quantitative models use machine learning technology to rank stocks of companies of U.S. domiciled companies and ADRs of any market capitalization.

Counterpoint Funds

Fund Family

Large Blend

Fund Category

19.96M

Net Assets

2023-11-28

Inception Date

Performance Overview: CPAI

Trailing returns as of 4/25/2024. Category is Large Blend.

YTD Return

CPAI
8.85%
Category
9.95%
 

1-Year Return

CPAI
0.00%
Category
27.24%
 

3-Year Return

CPAI
0.00%
Category
9.88%
 

People Also Watch

Holdings: CPAI

Top 10 Holdings (20.32% of Total Assets)

SymbolCompany% Assets
AGL
agilon health, inc. 2.10%
OSCR
Oscar Health, Inc. 2.09%
NVCR
NovoCure Limited 2.05%
SSRM.TO
SSR Mining Inc. 2.03%
HE
Hawaiian Electric Industries, Inc. 2.02%
PUBM
PubMatic, Inc. 2.01%
ENLC
EnLink Midstream, LLC 2.01%
PARR
Par Pacific Holdings, Inc. 2.01%
PTVE
Pactiv Evergreen Inc. 2.01%
KD
Kyndryl Holdings, Inc. 2.00%

Sector Weightings

SectorCPAI
Healthcare   18.19%
Energy   18.05%
Technology   15.86%
Industrials   11.91%
Utilities   2.03%
Real Estate   0.00%

Recent News: CPAI

Research Reports: CPAI

  • Analyst Report: Merck & Co., Inc.

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

    Rating
    Price Target
     
  • Analyst Report: International Business Machines Corporation

    IBM looks to be a part of every aspect of an enterprise’s IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 350,000 people. The company has a robust roster of 80,000 business partners to service 5,200 clients—which includes 95% of all Fortune 500. While IBM is a B2B company, IBM’s outward impact is substantial. For example, IBM manages 90% of all credit card transactions globally and is responsible for 50% of all wireless connections in the world.

    Rating
    Price Target
     
  • Analyst Report: Wells Fargo & Company

    Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.

    Rating
    Price Target
     
  • Analyst Report: Welltower Inc.

    Welltower owns a diversified healthcare portfolio of 2,100 in-place properties spread across the senior housing, medical office, and skilled nursing/post-acute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.

    Rating
    Price Target
     

Related Tickers